EGFR and central nervous system cancer: These findings build on earlier work implicating glial precursors in H3K27M gliomas [23, 24, 25, 26, 30, 44, 45, 46, 47, 52] and highlight the EGFR pathway's possible role in sustaining self‐renewal and blocking differentiation.